Related Experiment Video
Updated: May 21, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
FGFR1 cleavage and nuclear translocation regulates breast cancer cell behavior
Athina-Myrto Chioni1, Richard Grose
1Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, England, UK.
Abstract:
FGF-10 and its receptors, FGFR1 and FGFR2, have been implicated in breast cancer susceptibility and progression, suggesting that fibroblast growth factor (FGF) signaling may be co-opted by breast cancer cells. We identify a novel pathway downstream of FGFR1 activation, whereby the receptor is cleaved and traffics to the nucleus, where it can regulate specific target genes. We confirm Granzyme B (GrB) as the protease responsible for cleavage and show that blocking GrB activity stopped FGFR1 trafficking to the nucleus and abrogates the promigratory effect of FGF stimulation. We confirm the in vivo relevance of our findings, showing that FGFR1 localized to the nucleus specifically in invading cells in both clinical material and a three-dimensional model of breast cancer. We identify target genes for FGFR1, which exert significant effects on cell migration and may represent an invasive signature. Our experiments identify a novel mechanism by which FGF signaling can regulate cancer cell behavior and provide a novel therapeutic target for treatment of invasive breast cancer.
Insights
Fibroblast growth factor receptor 1 (FGFR1) is cleaved by Granzyme B (GrB) and moves to the nucleus, regulating genes involved in breast cancer cell migration. Blocking GrB inhibits this process, offering a potential therapeutic target for invasive breast cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Fibroblast growth factor (FGF) signaling, particularly involving FGF-10 and its receptors FGFR1 and FGFR2, is linked to breast cancer development.
- Breast cancer cells may exploit FGF signaling pathways for tumor progression.
Purpose of the Study:
- To elucidate a novel downstream pathway of FGFR1 activation in breast cancer.
- To identify the protease responsible for FGFR1 cleavage and its role in receptor trafficking.
- To investigate the functional consequences of FGFR1 nuclear localization on cancer cell behavior and identify target genes.
Main Methods:
- Investigated FGFR1 activation, cleavage, and nuclear translocation.
- Utilized Granzyme B (GrB) inhibition assays to assess its role in FGFR1 trafficking.
- Examined the effect of blocking GrB on FGF-stimulated cell migration.
- Validated findings in clinical breast cancer samples and a 3D cancer model.
- Identified FGFR1 target genes using molecular techniques.
Main Results:
- A novel pathway was identified where activated FGFR1 is cleaved and traffics to the nucleus.
- Granzyme B (GrB) was confirmed as the protease responsible for FGFR1 cleavage.
- Inhibition of GrB blocked FGFR1 nuclear translocation and abrogated the promigratory effect of FGF.
- Nuclear localization of FGFR1 was observed specifically in invading cells in clinical and model systems.
- Specific target genes regulated by nuclear FGFR1 were identified, influencing cell migration.
Conclusions:
- A novel mechanism of FGF signaling regulation involving FGFR1 cleavage and nuclear translocation has been discovered.
- This pathway, mediated by Granzyme B, plays a significant role in promoting breast cancer cell invasion.
- The identified FGFR1-regulated genes may constitute an invasive signature for breast cancer.
- This pathway presents a potential novel therapeutic target for treating invasive breast cancer.
More Related Videos
Related Concept Videos
Mitogens and the Cell Cycle
TGF - β Signaling Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Negative Regulator Molecules
Intracellular Signaling Affects Focal Adhesions
Some...

